Jonathan Schwartz - Aug 12, 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role: Chief Medical Officer & Clinical Development, SVP
Signature: /s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz
Stock symbol: RCKT
Transactions as of: Aug 12, 2022
Transactions value $: $0
Form type: 4
Date filed: 8/16/2022, 05:33 PM
Previous filing: Apr 4, 2022
Next filing: Sep 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RCKT	Restricted Stock Units	Award	$0	+22.9K		$0.00	22.9K	Aug 12, 2022	Common Stock	22.9K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2	The restricted stock units will become fully vested on August 12, 2025.

Remarks:

Chief Medical Officer & Clinical Development, SVP